Skip to main content
SpringerLink
Log in

The EMA has recommended a precautionary recall of one remaining batch of cidofovir [Vistide],

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EMA.European Medicines Agency recommends precautionary recall of remaining batch of Vistide manufactured at Ben Venue Laboratories. Media Release: 13 Dec 2011. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The EMA has recommended a precautionary recall of one remaining batch of cidofovir [Vistide],. React. Wkly. 1383, 2 (2012). https://doi.org/10.2165/00128415-201213830-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213830-00003

Keywords

Search

Navigation